Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Non-Current Assets: 2022-2025

  • Abivax's Non-Current Assets fell 15.06% to $38.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $38.0 million, marking a year-over-year decrease of 15.06%. This contributed to the annual value of $36.9 million for FY2024, which is 16.47% down from last year.
  • Abivax's Non-Current Assets amounted to $38.0 million in Q2 2025, which was up 5.31% from $36.1 million recorded in Q1 2025.
  • Over the past 5 years, Abivax's Non-Current Assets peaked at $44.7 million during Q2 2024, and registered a low of $36.1 million during Q1 2025.
  • Moreover, its 3-year median value for Non-Current Assets was $38.0 million (2025), whereas its average is $40.0 million.
  • As far as peak fluctuations go, Abivax's Non-Current Assets rose by 10.09% in 2023, and later dropped by 16.47% in 2024.
  • Quarterly analysis of 4 years shows Abivax's Non-Current Assets stood at $40.2 million in 2022, then rose by 10.09% to $44.2 million in 2023, then decreased by 16.47% to $36.9 million in 2024, then fell by 15.06% to $38.0 million in 2025.
  • Its Non-Current Assets stands at $38.0 million for Q2 2025, versus $36.1 million for Q1 2025 and $36.9 million for Q4 2024.